Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhejiang Haichang Biotech Co., Ltd.

Clinical trials sponsored by Zhejiang Haichang Biotech Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for liver cancer: drug combo targets tough cases Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 2

New hope for liver cancer: drug combo targets tough cases

Disease control Recruiting now

This study tests a new drug, WGI-0301, combined with sorafenib in 60 adults with advanced liver cancer that cannot be removed by surgery and has not responded to prior immunotherapy. The goal is to find the best dose and see if the combination can shrink tumors. Participants must…

Phase 2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC